FDA OKs emergency use of Co-Diagnostics coronavirus test

Co-Diagnostics (NASDAQ:CODX) is up 42% premarket on light volume in reaction to the FDA’s granting of Emergency Use Authorization for its Logix Smart Coronavirus COVID-19 Test that detects the RdRp gene of the SARS-CoV-2 virus.

It is available for purchase from the company’s Utah-based facility.

https://seekingalpha.com/news/3558492-fda-oks-emergency-use-of-co-diagnostics-coronavirus-test-shares-up-42-premarket